Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Clobetasol 0.05% cream 10% in Aqueous cream
1304000G0AADIDI
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% cream 10% in Generic Unguentum M cream
1304000G0AACZCZ
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% cream 25% in Cetomacrogol cream (Formula A)
1304000G0AADGDG
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% cream 25% in White soft paraffin
1304000G0AACQCQ
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% cream 30% in Aqueous cream
1304000G0AACXCX
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% cream 50% in Generic Unguentum M cream
1304000G0AADADA
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% cream 50% in White soft paraffin
1304000G0AACRCR
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% crm 25%/Propylene glycol 40% in Aqueous crm
1304000G0AADKDK
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% oint 20% in Cetomacrogol crm (Formula A)
1304000G0AADHDH
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% oint 25%/Dithranol 0.05% in WSP
1304000G0AADFDF
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% ointment 10% in Generic Unguentum M cream
1304000G0AACMCM
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% ointment 10% in White soft paraffin
1304000G0AACJCJ
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% ointment 25% in Generic Unguentum M cream
1304000G0AADEDE
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% ointment 25% in White soft paraffin
1304000G0AACKCK
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% ointment 30% in White soft paraffin
1304000G0AACSCS
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasol 0.05% ointment 50% in Emulsifying ointment
1304000G0AADJDJ
|
Clobetasol propionate | Clobetasol propionate | Skin | No data available |
|
Clobetasone 0.05% cream 50% in Aqueous cream
1304000H0AACMCM
|
Clobetasone butyrate (Topical) | Clobetasone butyrate | Skin | No data available |
|
Clobetasone 0.05% cream 50% in White soft paraffin
1304000H0AACPCP
|
Clobetasone butyrate (Topical) | Clobetasone butyrate | Skin | No data available |
|
Clobetasone 0.05% ointment 50% in White soft paraffin
1304000H0AACKCK
|
Clobetasone butyrate (Topical) | Clobetasone butyrate | Skin | No data available |
|
Clobetasone 0.1% eye drops
1104010F0AAAAAA
|
Clobetasone butyrate (Eye) | Clobetasone butyrate | Eye | No data available |
|
Cloe roll-on girdle
23300603016
|
Cloe roll-on girdle | Belts | Stoma Appliances | No data available |
|
Clofarabine 20mg/20ml solution for infusion vials
0801030AAAAAAAA
|
Clofarabine | Clofarabine | Malignant Disease and Immunosuppression | No data available |
|
Clofazimine 50mg capsules
0501100C0AAACAC
|
Clofazimine | Clofazimine | Infections | No data available |
|
Clomethiazole 250mg/5ml oral solution
0401010D0AAAEAE
|
Clomethiazole edisilate | Clomethiazole edisilate | Central Nervous System | No data available |
|
Clomipramine 250mg/5ml oral suspension
0403010F0AAASAS
|
Clomipramine hydrochloride | Clomipramine hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.